Print
17 April 2014
Marchmont Innovation News
OOO Fort, a Russian company, is launching a new pharmaceutical facility outside the city of Ryazan in Central Russia later this week, the Uzrf.ru portal for Russian healthcare institutions reported .
At inception, a small workshop will open in the village of Yaltunovo; further plans are for the new project to be adding production capacity as it evolves. Longer term, the new pharma is expected to create as many as 900 new skilled local jobs.
The factory will be manufacturing nano- and biotech-based drugs to treat infectious and somatic diseases. They have been developed by Fort’s own R&D staff in collaboration with a number of leading research centers of the Russian Academy of Medical Sciences.
The Ryazan project has taken about 30 months of construction and more than $130m in investment to complete.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.